#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2314	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2444	280.5	0	.	n	.	0	C1450T	SNP	1450	1450	C	1889	1889	T	317	T,C	271,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2314	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2444	280.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1623	1623	C	358	C,T	300,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2314	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2444	280.5	0	HET	.	.	.	A69G,C	.	69	69	A	508	508	A	342	A,G,C	217,73,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4008	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3827	312.3	0	.	n	.	0	G1337A	SNP	1337	1337	G	1779	1779	A	347	A	274	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4008	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3827	312.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2413	2413	C	401	C	315	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4008	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3827	312.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2487	2487	A	426	A,C	345,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4008	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3827	312.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	3039	3039	C	377	C,A	294,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	539	330	folP	852	852	99.88	folP.l15.c4.ctg.1	1763	55.6	0	.	p	.	0	E151K	NONSYN	451	453	GAA	992	994	AAA	77;77;75	A;A;A	62;65;62	.	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	539	330	folP	852	852	99.88	folP.l15.c4.ctg.1	1763	55.6	1	SNP	p	R228S	1	.	.	682	684	AGC	1223	1225	AGC	65;66;66	A,G;G;C	46,1;51;49	folP.WHO_K_01359c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	698	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3650	56.9	1	SNP	p	S91F	0	.	.	271	273	TCC	712	714	TCC	54;54;55	T,G;C;C	43,1;46;48	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	698	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3650	56.9	1	SNP	p	D95N	0	.	.	283	285	GAC	724	726	GAC	51;51;50	G;A;C	46;41;41	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	698	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3650	56.9	1	SNP	p	D95G	0	.	.	283	285	GAC	724	726	GAC	51;51;50	G;A;C	46;41;41	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	310	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1681	55.0	1	SNP	p	G45D	0	.	.	133	135	GGC	588	590	GGC	98;98;98	G;G,C;C	79;78,1;76	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	212	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1351	47.0	0	.	n	.	0	A197.	DEL	197	197	A	793	793	A	87	A	71	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	768	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3350	68.6	1	SNP	p	D86N	0	.	.	256	258	GAC	712	714	GAC	88;86;85	G;A;C	70;65;68	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	768	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3350	68.6	1	SNP	p	S87I	0	.	.	259	261	AGT	715	717	AGT	85;85;84	A;G;T	66;70;65	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	768	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3350	68.6	1	SNP	p	S87R	0	.	.	259	261	AGT	715	717	AGT	85;85;84	A;G;T	66;70;65	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	768	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3350	68.6	1	SNP	p	S87W	0	.	.	259	261	AGT	715	717	AGT	85;85;84	A;G;T	66;70;65	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	768	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3350	68.6	1	SNP	p	S88P	0	.	.	262	264	TCC	718	720	TCC	85;86;84	T;C;C	68;71;68	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	620	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2988	61.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1699	1701	GGC	92;93;93	G;G;C	73;73;74	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	604	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2696	66.7	1	SNP	p	A311V	0	.	.	931	933	GCA	1441	1443	GCA	80;81;79	G;C,A;A	63;59,1;61	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	604	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2696	66.7	1	SNP	p	I312M	0	.	.	934	936	ATC	1444	1446	ATC	79;79;79	A;T;C	64;60;61	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	604	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2696	66.7	1	SNP	p	V316T	0	.	.	946	948	GTG	1456	1458	GTG	77;77;77	G;T;G	60;60;61	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	604	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2696	66.7	1	SNP	p	V316P	0	.	.	946	948	GTG	1456	1458	GTG	77;77;77	G;T;G	60;60;61	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	604	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2696	66.7	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1960	1962	ACC	78;81;80	A;C;C	63;66;70	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	604	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2696	66.7	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2014	2016	GCG	83;84;84	G;C,G;G	66;63,1;66	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	604	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2696	66.7	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2014	2016	GCG	83;84;84	G;C,G;G	66;63,1;66	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	604	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2696	66.7	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2137	2139	GGC	83;83;83	G;G;C	70;67;70	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	604	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2696	66.7	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2146	2148	GGC	82;81;80	G;G;C,G	70;69;68,1	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	604	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2696	66.7	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2164	2166	CTG	85;84;84	C;T;G	68;63;68	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	794	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3510	67.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1816	1818	CCG	61;61;62	C;C;G	48;49;51	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	314	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2104	44.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	743	743	C	54	C	43	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	52	porB1a	984	295	90.3	porB1a.l6.c17.ctg.1	1218	11.3	0	.	p	.	0	H217N	NONSYN	649	651	CAT	947	949	AAT	10;10;10	A;A;T	8;8;7	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	52	porB1a	984	295	90.3	porB1a.l6.c17.ctg.1	1218	11.3	0	.	p	.	0	D218N	NONSYN	652	654	GAT	950	952	AAT	10;10;10	A;A;T	8;7;8	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	52	porB1a	984	295	90.3	porB1a.l6.c17.ctg.1	1218	11.3	0	.	p	.	0	V226A	NONSYN	676	678	GTA	974	976	GCA	10;10;10	G;C;A	8;8;8	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	52	porB1a	984	295	90.3	porB1a.l6.c17.ctg.1	1218	11.3	0	.	p	.	0	.	MULTIPLE	700	702	ACT	997	999	GTA	10;10;10	G;T;A	8;8;8	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	52	porB1a	984	295	90.3	porB1a.l6.c17.ctg.1	1218	11.3	0	.	p	.	0	S236N	NONSYN	706	708	AGC	1003	1005	AAC	10;10;10	A;A;C	8;8;8	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	52	porB1a	984	295	90.3	porB1a.l6.c17.ctg.1	1218	11.3	0	.	p	.	0	.	MULTIPLE	709	711	AAC	1007	1011	TGGCG	10;10;10;10;10	T;G;G;C;G	8;8;7;8;7	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	52	porB1a	984	295	90.3	porB1a.l6.c17.ctg.1	1218	11.3	0	.	p	.	0	D238A	NONSYN	712	714	GAT	1013	1015	GCT	10;10;10	G;C;T	8;8;7	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	52	porB1a	984	295	90.3	porB1a.l6.c17.ctg.1	1218	11.3	0	.	p	.	0	V258L	NONSYN	772	774	GTA	1073	1075	TTA	10;10;10	T;T;A	8;8;8	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	52	porB1a	984	295	90.3	porB1a.l6.c17.ctg.1	1218	11.3	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	1118	1120	CAT	11;11;11	C;A;T	9;9;8	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	52	porB1a	984	295	90.3	porB1a.l6.c17.ctg.1	1218	11.3	0	.	p	.	0	D274S	NONSYN	820	822	GAT	1121	1123	AGT	11;11;11	A;G;T	8;8;7	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	52	porB1a	984	295	90.3	porB1a.l6.c17.ctg.1	1218	11.3	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	1130	1132	TAC	11;11;12	T;A;C	9;8;9	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	500	porB1b	1047	1047	99.43	porB1b.l15.c4.ctg.1	1948	76.6	0	.	p	.	0	N38E	NONSYN	112	114	AAT	568	570	GAA	74;74;72	G;A;A	60;59;57	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	500	porB1b	1047	1047	99.43	porB1b.l15.c4.ctg.1	1948	76.6	0	.	p	.	0	N134D	NONSYN	400	402	AAT	856	858	GAT	102;101;101	G;A;T	82;79;82	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	500	porB1b	1047	1047	99.43	porB1b.l15.c4.ctg.1	1948	76.6	0	.	p	.	0	P175S	NONSYN	523	525	CCA	979	981	TCA	101;102;103	T,A;C;A	81,1;85;84	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	500	porB1b	1047	1047	99.43	porB1b.l15.c4.ctg.1	1948	76.6	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1108	1110	GTC	114;116;116	G;T;C	88;94;91	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	500	porB1b	1047	1047	99.43	porB1b.l15.c4.ctg.1	1948	76.6	1	SNP	p	G120K	1	.	.	358	360	AAG	814	816	AAG	95;95;95	A;A;G	76;77;77	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	500	porB1b	1047	1047	99.43	porB1b.l15.c4.ctg.1	1948	76.6	1	SNP	p	A121D	1	.	.	361	363	GAC	817	819	GAC	95;95;95	G;A;C	75;79;76	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	500	porB1b	1047	1047	99.43	porB1b.l15.c4.ctg.1	1948	76.6	1	SNP	p	D121N	0	.	.	361	363	GAC	817	819	GAC	95;95;95	G;A;C	75;79;76	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	1658	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	5331	92.8	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2294	2296	AAT	82;82;82	A;A;T	69;68;67	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	266	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1384	56.9	1	SNP	p	V57M	1	.	.	169	171	ATG	615	617	ATG	109;109;110	A;T;G	97;96;97	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
